Overview

Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia

Status:
Not yet recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This randomised controlled trial will determine the non-inferiority of stopping empiric antibiotics prior to absolute neutrophil count (ANC) recovery (Early Stopping) versus stopping antibiotics upon ANC recovery (Standard of Care/ Late Stopping) , in children with cancer and high-risk febrile neutropenia (FN).
Phase:
Phase 4
Details
Lead Sponsor:
Murdoch Childrens Research Institute
Treatments:
Amikacin
Cefepime
Ceftazidime
Ciprofloxacin
Piperacillin
Tazobactam
Vancomycin